© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
Law and Regulations
The Evolution of the CBD Regulatory Landscape
September 13, 2022
No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.
Impact of Laws on Pediatric Opioid Prescriptions
September 08, 2022
Are prescription cap laws for opioids effective for children and teenagers?
As Health Care Providers, Pharmacists Must Advocate for What They Need and What Patients Deserve
September 02, 2022
Continued advocacy work is the key to seeing state and federal legislative action come to fruition.
Potential Drug-Diversion Cases Frequently Go Uninvestigated
July 21, 2022
Although one in 12 controlled substances medication transactions at US hospitals involve suspicious variations, only about half of such transactions are ever investigated.
FDA Approves Ruxolitinib Cream 1.5% to Treat Nonsegmental Vitiligo
July 20, 2022
Ruxolitinib (Opzelura) cream is the first and only FDA-approved treatment for patients with vitiligo.
Breaking: Pharmacists Authorized by FDA to Prescribe Paxlovid, With Limitations
July 06, 2022
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
Supreme Court Issues Ruling on Opioid Prescriptions
June 29, 2022
Ruling comes in cases with prison sentences for convictions over prescription drugs.
NCPA Announces Support for Bipartisan PBM Transparency Bill
May 31, 2022
The bill allows state attorneys general and the Federal Trade Commission the ability to initiate legal action against certain PBM business practices.